Sigal Charles Elliott
SEC insider (Form 3/4/5 filer). CIK 0001661908. Director at Vir Biotechnology, Inc. (VIR) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 27, 2026. Located in CAMBRIDGE, MA.
Companies Sigal Charles Elliott has filed insider reports for
- Vir Biotechnology, Inc. (VIR): Director
- ALNYLAM PHARMACEUTICALS, INC. (ALNY): Director
Sigal Charles Elliott
CIK: 0001661908
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 27, 2026VIR
Vir Biotechnology, Inc.
AwardDirect8K shares- - May 20, 2026ALNY
ALNYLAM PHARMACEUTICALS, INC.
AwardDirect671 shares- - May 30, 2025VIR
Vir Biotechnology, Inc.
AwardDirect8K shares- - May 8, 2025ALNY
ALNYLAM PHARMACEUTICALS, INC.
AwardDirect775 shares-
1-4 of 4 transactions